Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-10-11

Clinical Trial Update: TOFO Insulin Combination Trial [Phase 4]

View source ↗

Summary

Sanofi-sponsored TOFO-insulin combination trial in Type 2 Diabetes Mellitus has completed Phase 4. The excerpt provides trial status but does not report results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Insulin (insulin)
  • TOFO (tofogliflozin) (tofogliflozin)

Snippet

Sponsor: Sanofi | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED